TianKang Biological Co., Ltd.
Securities Code: 002100
Securities Abbreviation: TianKang Biological
Announcement No.: 2026-041
TianKang Biological Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, without any false records, misleading statements, or significant omissions. The 2025 annual equity distribution plan has been approved by the shareholders' meeting held on May 20, 2026. The details of the equity distribution are as follows: